Research / ZS / Fundamental state Inspectable configuration
State dimensions Filing 0001713683-20-000163 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
199.79% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 75th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.capex_revenue_ratio
9.99% · OPTIONAL · VALID
Operating cash generation 50th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
18.39% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
42.41% · CORE · NOT_ENOUGH_HISTORY
Gross margin 11th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.gross_margin
77.80% · CORE · VALID
Operating margin 11th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.operating_margin
-26.42% · CORE · VALID
R&D intensity 100th Own-history percentile · N=9
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
22.70% · OPTIONAL · VALID
SBC intensity 100th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
28.15% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Oct 31, 2021 7/8 normalized Level 3 Jan 31, 2022 5/6 normalized Level 3 Apr 30, 2022 7/8 normalized Level 3 Jul 31, 2022 8/8 normalized Level 3 Oct 31, 2022 8/8 normalized Level 3 Jan 31, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Jul 31, 2023 8/8 normalized Level 3 Oct 31, 2023 8/8 normalized Level 3 Jan 31, 2024 6/6 normalized Level 3 Apr 30, 2024 8/8 normalized Level 3 Jul 31, 2024 8/8 normalized Level 3 Oct 31, 2024 8/8 normalized Level 3 Jan 31, 2025 8/8 normalized Level 3 Apr 30, 2025 8/8 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 8.77%
Current 9.99%
Delta 1.22% Cash Generation Decreased
Previous 18.84%
Current 18.39%
Delta -0.45% Growth Increased
Previous 39.68%
Current 42.41%
Delta 2.73% Margin Increased
Previous 77.76%
Current 77.80%
Delta 0.04% Profitability Decreased
Previous -18.56%
Current -26.42%
Delta -7.86% R And D Intensity Increased
Previous 21.82%
Current 22.70%
Delta 0.88% Sbc Intensity Increased
Previous 25.13%
Current 28.15%
Delta 3.02% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.